• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于癌症放射治疗的铜死亡纳米胶囊。

A cuproptosis nanocapsule for cancer radiotherapy.

作者信息

Liao You, Wang Dongmei, Gu Chenglu, Wang Xue, Zhu Shuang, Zheng Ziye, Zhang Fuquan, Yan Junfang, Gu Zhanjun

机构信息

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, China.

College of Materials Science and Optoelectronic Technology, University of Chinese Academy of Sciences, Beijing, China.

出版信息

Nat Nanotechnol. 2024 Dec;19(12):1892-1902. doi: 10.1038/s41565-024-01784-1. Epub 2024 Sep 19.

DOI:10.1038/s41565-024-01784-1
PMID:39300223
Abstract

Residual tumours that persist after radiotherapy often develop acquired radiation resistance, increasing the risk of recurrence and metastasis while providing obstacles to re-irradiation. Using samples from patients and experimental mice, we discovered that FDX1 and LIAS, key regulators of cuproptosis, were up-regulated in residual tumours following radiotherapy, conferring the increased sensitivity to cuproptosis. Therefore, we proposed a novel radiosensitization strategy focused on cuproptosis, using a copper-containing nanocapsule-like polyoxometalate as a paradigm. In an initial demonstration, we showed that the nanocapsule released copper ions in a controlled manner upon exposure to ionizing radiation. Furthermore, radiation-triggered cuproptosis overcame acquired radiation resistance even at clinically relevant radiation doses and activated a robust abscopal effect, with a 40% cure rate in both radioresistant and re-irradiation tumour models. Collectively, targeting cuproptosis is a compelling strategy for addressing acquired radiation resistance, optimizing the local antitumour effects of radiotherapy while simultaneously activating systemic antitumour immunity.

摘要

放疗后持续存在的残留肿瘤通常会产生获得性放射抗性,增加复发和转移风险,同时给再次放疗带来障碍。利用患者样本和实验小鼠,我们发现铜死亡的关键调节因子FDX1和LIAS在放疗后的残留肿瘤中上调,使肿瘤对铜死亡的敏感性增加。因此,我们提出了一种以铜死亡为重点的新型放射增敏策略,以含铜纳米胶囊状多金属氧酸盐为范例。在初步验证中,我们表明该纳米胶囊在暴露于电离辐射时以可控方式释放铜离子。此外,辐射触发的铜死亡即使在临床相关辐射剂量下也能克服获得性放射抗性,并激活强大的远隔效应,在放射抗性和再次放疗肿瘤模型中的治愈率均为40%。总的来说,靶向铜死亡是解决获得性放射抗性、优化放疗局部抗肿瘤效果同时激活全身抗肿瘤免疫的一种有吸引力的策略。

相似文献

1
A cuproptosis nanocapsule for cancer radiotherapy.一种用于癌症放射治疗的铜死亡纳米胶囊。
Nat Nanotechnol. 2024 Dec;19(12):1892-1902. doi: 10.1038/s41565-024-01784-1. Epub 2024 Sep 19.
2
Synergistic enhancement of low-dose radiation therapy via cuproptosis and metabolic reprogramming for radiosensitization in in situ hepatocellular carcinoma.通过铜死亡和代谢重编程协同增强低剂量放射治疗对原位肝细胞癌的放射增敏作用。
J Nanobiotechnology. 2024 Dec 19;22(1):772. doi: 10.1186/s12951-024-03011-4.
3
Cuproptosis-Inducing Functional Nanocomposites for Enhanced and Synergistic Cancer Radiotherapy.用于增强和协同癌症放射治疗的促铜死亡功能纳米复合材料
ACS Nano. 2025 Feb 11;19(5):5429-5446. doi: 10.1021/acsnano.4c13753. Epub 2025 Feb 2.
4
Manipulating Radiation-Sensitive Z-DNA Conformation for Enhanced Radiotherapy.通过操纵辐射敏感的Z-DNA构象增强放射治疗
Adv Mater. 2024 Jul;36(29):e2313991. doi: 10.1002/adma.202313991. Epub 2024 May 9.
5
Assembly of a biomimetic copper-based nanocomplex for alleviating hypoxia to enhance cuproptosis against osteosarcoma and lung metastasis.组装一种仿生铜基纳米复合物以缓解缺氧,增强对骨肉瘤及肺转移的铜死亡作用。
Acta Biomater. 2025 Jan 24;193:348-361. doi: 10.1016/j.actbio.2024.12.049. Epub 2024 Dec 20.
6
Tumor Microenvironment Responsive and Platelet Membrane Coated Polydopamine Nanoparticles for Cancer Radiosensitization by Inducing Cuproptosis.肿瘤微环境响应性及血小板膜包覆的聚多巴胺纳米颗粒通过诱导铜死亡实现癌症放射增敏
Int J Nanomedicine. 2025 Mar 19;20:3643-3652. doi: 10.2147/IJN.S504148. eCollection 2025.
7
Tumor Microenvironment Reprogrammed Bimetallic Hybrid Nanostimulator for Triggering Radio-Cuproptosis-Immunotherapy.用于触发放射性铜死亡免疫疗法的肿瘤微环境重编程双金属杂化纳米刺激器
Adv Healthc Mater. 2024 Dec;13(30):e2401902. doi: 10.1002/adhm.202401902. Epub 2024 Aug 13.
8
Role of metabolism in cancer cell radioresistance and radiosensitization methods.代谢在癌细胞放射抗性和放射增敏方法中的作用。
J Exp Clin Cancer Res. 2018 Apr 23;37(1):87. doi: 10.1186/s13046-018-0758-7.
9
Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer.放射增敏相关铜死亡长链非编码 RNA 标志物在非小细胞肺癌中的研究
Genes (Basel). 2022 Nov 9;13(11):2080. doi: 10.3390/genes13112080.
10
Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation.仿生金纳米笼结合铜-人血清白蛋白通过铜死亡-乳酸调控进行肿瘤免疫治疗。
J Control Release. 2024 Aug;372:446-466. doi: 10.1016/j.jconrel.2024.06.059. Epub 2024 Jun 26.

引用本文的文献

1
Programmed Cell Death in Cancer.癌症中的程序性细胞死亡
MedComm (2020). 2025 Aug 31;6(9):e70357. doi: 10.1002/mco2.70357. eCollection 2025 Sep.
2
Radiotherapy-Activated Prodrug: Past, Present and Beyond.放射治疗激活前药:过去、现在与未来
ACS Cent Sci. 2025 Jul 16;11(8):1306-1320. doi: 10.1021/acscentsci.5c00875. eCollection 2025 Aug 27.
3
Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy.利用核酸纳米颗粒的免疫学特性改善癌症治疗

本文引用的文献

1
Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers.复发性妇科癌症中应用先进近距离放疗技术的再放疗。
Brachytherapy. 2023 Nov-Dec;22(6):753-760. doi: 10.1016/j.brachy.2023.07.004. Epub 2023 Sep 15.
2
Trace Cu(II)-Mediated Selective Oxidation of Benzothiazole: The Predominance of Sequential Cu(II)-Cu(I)-Cu(III) Valence Transition and Dissolved Oxygen.痕量 Cu(II)介导的苯并噻唑选择性氧化:连续的 Cu(II)-Cu(I)-Cu(III)价态转变和溶解氧的优势。
Environ Sci Technol. 2023 Aug 22;57(33):12523-12533. doi: 10.1021/acs.est.3c04134. Epub 2023 Aug 8.
3
Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
RNA Nanomed. 2025 Apr;2(1). doi: 10.59566/isrnn.2025.0201b.
4
Engineered anti-cancer nanomedicine for synergistic cuproptosis-immunotherapy.用于协同铜死亡免疫治疗的工程化抗癌纳米药物
Mater Today Bio. 2025 Jul 29;34:102133. doi: 10.1016/j.mtbio.2025.102133. eCollection 2025 Oct.
5
Hybrid Cell Membrane-Functionalized Nanoagents Synergistically Enhance Cuproptosis-Mediated Immunotherapy by Dual Modulation of Glycolytic Metabolism and Tumor Microenvironments.杂交细胞膜功能化纳米制剂通过对糖酵解代谢和肿瘤微环境的双重调节协同增强铜死亡介导的免疫治疗
ACS Nano. 2025 Aug 12;19(31):28913-28932. doi: 10.1021/acsnano.5c10671. Epub 2025 Aug 4.
6
CuOTeDsP nanotherapeutics enhance cuproptosis-mediated immunotherapy by modulating cholesterol metabolism in bladder cancer.CuOTeDsP纳米疗法通过调节膀胱癌中的胆固醇代谢增强铜死亡介导的免疫疗法。
J Nanobiotechnology. 2025 Jul 22;23(1):534. doi: 10.1186/s12951-025-03609-2.
7
From mechanism to application: programmed cell death pathways in nanomedicine-driven cancer therapies.从机制到应用:纳米医学驱动的癌症治疗中的程序性细胞死亡途径
Bioact Mater. 2025 Jul 1;52:773-809. doi: 10.1016/j.bioactmat.2025.06.052. eCollection 2025 Oct.
8
Targeted ZnO@CuEA Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy.用于基于铜死亡的协同癌症治疗的靶向性氧化锌@铜-乙二胺纳米平台
J Cell Mol Med. 2025 Jun;29(11):e70636. doi: 10.1111/jcmm.70636.
9
Cuproptosis as a therapeutic target in cancer: a Systematic Review and bibliometric analysis of the research landscape.铜死亡作为癌症治疗靶点:研究现状的系统评价与文献计量分析
Front Oncol. 2025 May 16;15:1566986. doi: 10.3389/fonc.2025.1566986. eCollection 2025.
10
Cuproptosis-related genes and agents: implications in tumor drug resistance and future perspectives.铜死亡相关基因与药物:对肿瘤耐药性的影响及未来展望
Front Pharmacol. 2025 May 8;16:1559236. doi: 10.3389/fphar.2025.1559236. eCollection 2025.
根治性调强放疗/旋转容积调强放疗后局部复发的食管鳞癌再放疗。
Radiat Oncol. 2023 Jul 10;18(1):114. doi: 10.1186/s13014-023-02265-w.
4
Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge.载 I 型 AIE 光敏剂仿生体系增强铜死亡以抑制乳腺癌转移和再挑战
ACS Nano. 2023 Jun 13;17(11):10206-10217. doi: 10.1021/acsnano.3c00326. Epub 2023 May 15.
5
Radiotherapy modulates tumor cell fate decisions: a review.放疗调节肿瘤细胞命运决策:综述。
Radiat Oncol. 2022 Dec 1;17(1):196. doi: 10.1186/s13014-022-02171-7.
6
Formed Z-Scheme Graphdiyne Heterojunction Realizes NIR-Photocatalytic Oxygen Evolution and Selective Radiosensitization for Hypoxic Tumors.形成的Z型石墨炔异质结实现近红外光催化析氧及对缺氧肿瘤的选择性放射增敏作用。
ACS Nano. 2022 Dec 27;16(12):21186-21198. doi: 10.1021/acsnano.2c09169. Epub 2022 Nov 29.
7
Copper homeostasis and cuproptosis in health and disease.铜稳态和铜死亡在健康和疾病中的作用。
Signal Transduct Target Ther. 2022 Nov 23;7(1):378. doi: 10.1038/s41392-022-01229-y.
8
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.放疗联合 CD47 阻断可引发巨噬细胞介导的远隔效应。
Nat Cancer. 2022 Nov;3(11):1351-1366. doi: 10.1038/s43018-022-00456-0. Epub 2022 Nov 21.
9
European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making.欧洲放射肿瘤学会和欧洲癌症研究与治疗组织关于再放疗的共识:定义、报告和临床决策。
Lancet Oncol. 2022 Oct;23(10):e469-e478. doi: 10.1016/S1470-2045(22)00447-8.
10
Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death.铜死亡:铜诱导细胞死亡的细胞和分子机制。
Mol Cell. 2022 May 19;82(10):1786-1787. doi: 10.1016/j.molcel.2022.05.001.